Ginsenoside Rh2 Inhibits Glycolysis through the STAT3/c-MYC Axis in Non-Small-Cell Lung Cancer

Ginsenoside Rh2 (Rh2) is one of the pharmacologically active components of ginseng with an antitumor effect. However, its effect on non-small-cell lung cancer (NSCLC), especially on aerobic glycolysis, which plays a crucial role in the proliferation and progression of tumor cells, has not been chara...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiaodan, Zhao, Peiyan, Li, Hui, Liu, Yan, Wang, Tianming, Cheng, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487371/
https://www.ncbi.nlm.nih.gov/pubmed/34608390
http://dx.doi.org/10.1155/2021/9715154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487371/
https://www.ncbi.nlm.nih.gov/pubmed/34608390
http://dx.doi.org/10.1155/2021/9715154

Ejemplares similares